
迈向“精准全球化”——来自医药行业的启示
在“精准全球化”的新时代,跨国企业必须有能力将全球最优解决方案与本土实际需求精准适配。
Appointed as Chief Executive Officer on May 1, 2026, Belén Garijo is leading Sanofi into its next phase of growth by advancing its scientific roadmap, strengthening execution, and fostering a culture of excellence. She brings deep scientific expertise and a strong track record of sustainable results at the intersection of R&D, strategy, and business model transformation.
Previously, Belén served as Chair of the Executive Board and Chief Executive Officer of Merck, holding various positions within the company since joining in 2011. Before joining Merck, she served as a Senior Vice President of Global Operations Europe at Sanofi-Aventis, where she led the integration of Genzyme following its acquisition. She has also held several leadership positions in R&D and commercial development within the healthcare sector.
Belén is a physician specializing in clinical pharmacology. She began her career as a practicing physician at La Paz Hospital in Madrid, Spain.
在“精准全球化”的新时代,跨国企业必须有能力将全球最优解决方案与本土实际需求精准适配。
In this new era of 'precision globalization', multinational companies must be able to tune the best available global solutions to local needs.
In the intelligent age, businesses can take four steps to not only to create a future-ready workforce, but also develop trust-based leadership as a strong foundation for AI use.
The concept of 'bioconvergence' brings together experts, processes, and technologies across biotech, software, and engineering, to meet today's challenges.
Resilience enables companies to thrive during challenging times, says the CEO of Merck, who details the three types of resilience that can help businesses grow.
Digital health: The integration of data, biotech and digital technologies into services is transforming the way healthcare stakeholders approach research and patient care
Schistosomiasis, also known as bilharzia, is a neglected tropical disease that kills 200,000 of the world's poorest each year. Here's how to eliminate it.
The work of inaugural Johann Anton Merck award winner Professor Caroline Dive is making testing for cancer simpler and more accessible to more patients.
新型コロナウイルスの大流行により介護の必要性が増し、予期せぬ大きな課題が提起される中、介護者を認識し、評価し、性差による偏向を減らしていくことの緊急性が高まっています。特に、リソースが限られ、患者の多くが入院できない状況において、新型コロナウイルスの患者とその家族にとって、緩和ケアおよび終末期ケアは必要性の高いものとなると考えられます。
This crisis presents an opportunity to develop new policies and implement flexible working for carers to promote gender equality in the home and workplace.
From the use of artificial intelligence in drug development to innovations in clinical trials, innovation is on the horizon.
Closing the gender pay gap is a necessary goal in itself - but research shows that companies with a greater number of women in leadership outperform their peers
Looking at disease on a molecular level is driving the trend towards treatment tailored to the individual patient.











